Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks inch lower on mixed data and earnings

Wed, 23rd Apr 2014 11:37

- AB Foods jumps, ARM and Sports Direct fall- UK borrowing falls more than expected- Chinese manufacturing still in contraction- Eurozone business activity improvestechMARK 2,740.84 +0.09%FTSE 100 6,670.05 -0.18%FTSE 250 15,991.94 -0.56%UK stocks pulled back from a three-week high on Wednesday, but were trading within a narrow range as investors digested mixed economic data and a host of corporate earnings.Primark owner Associated British Foods was a stand-out performer, rising sharply after announcing plans to open its first store in the States as it rolls out the fast-growing fashion outlet overseas.Quarterly trading updates from ARM Holdings and Sports Direct, however, disappointed investors this morning with both stocks falling sharply.The FTSE 100 was down 12 points, or 0.2%, at 6,670.05 by midday, with just 27 points separating its intra-day low and high.The index gained 0.9% on Tuesday on the back of heightened M&A activity and bid speculation in the global pharmaceutical sector, rising to 6,681.76, its highest close since April 4th. In economic data today, UK public sector net borrowing slipped to £6.7bn in March, from £8.8bn the month before, according to the Office for National Statistics, well below the consensus estimate of £11bn.Purchasing managers' indices (PMIs) from across the globe were also in focus, including a private survey in China which showed that the manufacturing sector contracted for a fourth straight month in April. The PMI improved from 48 to 48.3, in line with expectations but still under the key 50-point threshold that separates growth from contraction.The Eurozone composite PMI rose from 53.1 to a 35-month high of 54 in April, ahead of expectations, as activity in both manufacturing and services increased. The manufacturing PMI in the US is also due out later on and is expected to show that growth picked up this month. Meanwhile, results from Wall Street giants Apple and Facebook after the closing bell this evening will likely be closely watched by investors.In other news, the minutes of the Monetary Policy Committee's last rate-setting meeting showed that the decision to keep monetary policy unchanged was supported by the full majority of its members.AB Foods jumps on US expansion, resultsAB Foods jumped after saying that it would open new Primark stores in north-east US. The chain, which already has stores in nine countries in Western Europe, has signed a lease for 70,000 square feet of selling space in Boston and will open the shop towards the end of 2015. Further stores are planned across the wider region through to the middle of 2016.The company also reported a 4% increase in adjusted pre-tax profits to £468m for the 24 weeks to March 1st, helped by a 26% jump in operating profits at Primark.AstraZeneca was continuing to rise on speculation that US pharmaceutical peer Pfizer could offer as much as £60bn to buy the company, representing the largest foreign takeover of a UK business on record. The stock, which rose 5% yesterday, was making solid gains this morning.Similarly, GlaxoSmithKline extended gains after yesterday unveiling a massive three-part deal with Swiss firm Novartis, under which shareholders will receive a £4bn a capital return.Chip designer ARM Holdings declined after the company's first-quarter results showed strong licensing revenues and weak royalties. Analysts at finnCap said that company remains on track to hit forecasts but it "is just not showing the growth rates to see the shares push beyond the current price-to-earnings ratio of 40".High street sporting goods retailer Sports Direct was also lower after seeing a slight slowdown in growth in the fourth quarter. The company also warned of "further uncertainty" arising from its decision to cancel a controversial bonus payout to founder Mike Ashley earlier this month.Retail-focused property group Hammerson rose after giving a confident outlook, saying that an improving UK recovery filtered through to demand in the first quarter.Antofagasta was trading firmly in the red this morning after going ex-dividend, meaning that from today new investors won't be able to obtain the company's latest payout. FTSE 100-listed peers Aggreko, BG Group, Centrica, Legal & General, Mondi, Old Mutual and Rolls-Royce were also trading without the rights to their latest dividends this morning.A number of FTSE 250 stocks were also lower after going ex-dividend, including Hikma, Drax, Kentz and Tullett Prebon.FTSE 100 - RisersAssociated British Foods (ABF) 2,962.00p +8.82%Admiral Group (ADM) 1,399.00p +2.64%AstraZeneca (AZN) 4,038.00p +1.97%Randgold Resources Ltd. (RRS) 4,683.00p +1.69%Royal Mail (RMG) 530.50p +1.63%Tesco (TSCO) 296.90p +1.54%Wolseley (WOS) 3,410.00p +1.46%Land Securities Group (LAND) 1,073.00p +1.42%Experian (EXPN) 1,121.00p +1.26%Hammerson (HMSO) 580.00p +1.05%FTSE 100 - FallersAntofagasta (ANTO) 794.50p -5.92%Centrica (CNA) 330.80p -4.09%Sports Direct International (SPD) 799.50p -3.67%Old Mutual (OML) 196.60p -3.63%Morrison (Wm) Supermarkets (MRW) 197.30p -3.33%ARM Holdings (ARM) 954.50p -2.90%Aberdeen Asset Management (ADN) 432.20p -2.61%Legal & General Group (LGEN) 207.00p -2.45%Ashtead Group (AHT) 878.50p -2.44%Standard Chartered (STAN) 1,282.00p -2.25%FTSE 250 - RisersSpirent Communications (SPT) 104.80p +8.49%Fenner (FENR) 409.40p +4.97%Merlin Entertainments (MERL) 365.30p +3.72%Centamin (DI) (CEY) 54.65p +3.31%Thomas Cook Group (TCG) 179.30p +3.28%Petra Diamonds Ltd.(DI) (PDL) 154.90p +2.79%Daejan Holdings (DJAN) 4,984.00p +1.67%SEGRO (SGRO) 349.40p +1.28%3i Group (III) 391.70p +1.27%Caledonia Investments (CLDN) 2,100.00p +1.20%FTSE 250 - FallersDrax Group (DRX) 662.00p -12.49%Tullett Prebon (TLPR) 294.40p -5.67%Imagination Technologies Group (IMG) 183.00p -4.29%Moneysupermarket.com Group (MONY) 179.00p -4.07%Balfour Beatty (BBY) 289.60p -3.40%Ocado Group (OCDO) 363.00p -2.94%Man Group (EMG) 100.30p -2.72%Bellway (BWY) 1,534.00p -2.67%International Public Partnerships Ltd. (INPP) 126.10p -2.47%Victrex plc (VCT) 1,948.00p -2.31%BC
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.